JMS Co Ltd operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JMS Co Ltd with three other
companies in this sector in Japan:
Medikit Co Ltd
sales of 18.50 billion Japanese Yen [US$170.03 million]
of which 100%
was Medical equipment Production Sale),
Asahi Intecc Co., Ltd.
(57.22 billion Japanese Yen [US$525.82 million]
of which 84%
was Medical), and
Kawasumi Laboratories, Incorporated
(24.10 billion Japanese Yen [US$221.52 million]
of which 53%
was Extracorporeal Circulation-Related).
JMS Co Ltd reported sales of ¥58.06 billion (US$533.56 million)
March of 2019.
increase of 2.7%
versus 2018, when the company's sales were ¥56.52 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, JMS Co Ltd had sales
of ¥53.86 billion.
Sales of Operating Segment-China saw an increase
that was more than double the company's growth rate: sales were up
8.9% in 2019, from
¥1.43 billion to ¥1.56 billion.
JMS Co Ltd also saw significant increases in sales in
Operating Segment-Singapore (up 5.8% to ¥9.91 billion)
Not all segments of JMS Co Ltd experienced an increase in sales in 2019:
sales of Others fell 37.5% to ¥4.85 billion.